Trial · NCT01078389
Adverse events108
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 108
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Diarrhoea | Gastrointestinal disorders | Febuxostat 40 mg or 80 mg | 9 | 157 | |
| other | Diarrhoea | Gastrointestinal disorders | Placebo | 6 | 157 | |
| other | Oedema peripheral | General disorders | Febuxostat 40 mg or 80 mg | 8 | 157 | |
| other | Oedema peripheral | General disorders | Placebo | 5 | 157 | |
| other | Upper respiratory tract infection | Infections and infestations | Febuxostat 40 mg or 80 mg | 15 | 157 | |
| other | Upper respiratory tract infection | Infections and infestations | Placebo | 16 | 157 | |
| other | Aspartate aminotransferase increased | Investigations | Febuxostat 40 mg or 80 mg | 11 | 157 | |
| other | Aspartate aminotransferase increased | Investigations | Placebo | 6 | 157 | |
| other | Blood creatine phosphokinase increased | Investigations | Febuxostat 40 mg or 80 mg | 9 | 157 | |
| other | Blood creatine phosphokinase increased | Investigations | Placebo | 11 | 157 | |
| other | Alanine aminotransferase increased | Investigations | Febuxostat 40 mg or 80 mg | 10 | 157 | |
| other | Alanine aminotransferase increased | Investigations | Placebo | 6 | 157 | |
| other | Gamma-glutamyltransferase increased | Investigations | Febuxostat 40 mg or 80 mg | 6 | 157 | |
| other | Gamma-glutamyltransferase increased | Investigations | Placebo | 9 | 157 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Febuxostat 40 mg or 80 mg | 14 | 157 | |
| other | Arthralgia | Musculoskeletal and connective tissue disorders | Placebo | 10 | 157 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Febuxostat 40 mg or 80 mg | 9 | 157 | |
| other | Pain in extremity | Musculoskeletal and connective tissue disorders | Placebo | 13 | 157 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Febuxostat 40 mg or 80 mg | 9 | 157 | |
| other | Back pain | Musculoskeletal and connective tissue disorders | Placebo | 6 | 157 |
Source ClinicalTrials.govtrials-2026-11-12-0.4.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01078389/events